Evolutionarily conserved enhancer-associated features within the <i>MYEOV</i> locus suggest a regulatory role for this non-coding DNA region in cancer.
Ontology highlight
ABSTRACT: The myeloma overexpressed gene (MYEOV) has been proposed to be a proto-oncogene due to high RNA transcript levels found in multiple cancers, including myeloma, breast, lung, pancreas and esophageal cancer. The presence of an open reading frame (ORF) in humans and other primates suggests protein-coding potential. Yet, we still lack evidence of a functional MYEOV protein. It remains undetermined how MYEOV overexpression affects cancerous tissues. In this work, we show that MYEOV has likely originated and may still function as an enhancer, regulating CCND1 and LTO1. Firstly, MYEOV 3' enhancer activity was confirmed in humans using publicly available ATAC-STARR-seq data, performed on B-cell-derived GM12878 cells. We detected enhancer histone mar
SUBMITTER: Davidson BSA
PROVIDER: S-EPMC11319300 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature
ACCESS DATA